
Loading, please wait...

Loading, please wait...

Visualizing intracellular signaling at the nanoscale remains a significant challenge for modern researchers. However, the introduction of the BioSenSRRF microscopy technique offers a powerful solution. This method combines FRET biosensors with super-resolution radial fluctuations to track molecular dynamics. This approach allows scientists to track kinase activity with sub-diffraction precision without modifying existing probes. Moreover, it utilizes standard microscopy setups, making it highly accessible for laboratories across India and globally. Specifically, it uses publicly available image analysis tools to enhance spatial resolution significantly.
Aurora kinase A (AURKA) serves as a critical regulator of mitochondrial physiology. Notably, this kinase acts in specific subcellular compartments to manage energy production. Consequently, the research team used the BioSenSRRF microscopy technique to uncover how AURKA activation occurs. They found that mitochondrial AURKA activity is confined to specific domains. Furthermore, these subdomains contain ATP synthase, which is the enzyme responsible for cellular energy. Because of this, the kinase directly shapes mitochondrial compartments through its catalytic activity.
The research also highlights a vital link between kinase activity and oncology. Similarly, the study examined the cancer-associated polymorphism F31I. To illustrate, this specific genetic variant enhances AURKA activation within ATP synthase-enriched subdomains. Therefore, it promotes significantly higher ATP production levels in cancer cells. In fact, these metabolic changes may directly contribute to tumor survival and disease progression. Using validated inhibitors, researchers showed they could alter these activated subdomains, suggesting a target for future therapies.
Ultimately, BioSenSRRF provides a broadly accessible framework for improving the spatial resolution of genetically encoded biosensors. By using this framework, scientists can now investigate the organization of signaling molecules with unprecedented clarity. This progress will likely refine our understanding of mitochondrial contributions to both healthy physiology and cancer pathology. In conclusion, the strategy opens new avenues for dissecting the complex cellular architecture of kinases.
It combines conventional FRET biosensors with super-resolution radial fluctuations (SRRF) to achieve nanoscale resolution. This allows standard microscopes to visualize activity that was previously too small to see.
AURKA localizes to specific mitochondrial domains where it interacts with ATP synthase. This interaction regulates the enzyme's activity and helps maintain the organelle's metabolic output.
The F31I variant in the AURKA gene increases kinase activation and ATP production within mitochondria. These metabolic alterations are often linked to enhanced tumor growth and cancer risk.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
Jolivet NY et al. Combining Fret and Super-Resolution Microscopy Reveals Kinase Activation and Mitochondrial Activity at the Nanoscale. Adv Sci (Weinh). 2026 Jun 02. doi: 10.1002/advs.202522243. PMID: 42227232.
Sharma RK, Chafik A, Bertolin G. Aurora kinase A/AURKA functionally interacts with the mitochondrial ATP synthase to regulate energy metabolism and cell death. Cell Death Discov. 2023 Jun 29;9(1):203.
Bertolin G, et al. Aurora kinase A localises to mitochondria to control organelle dynamics and energy production. eLife. 2018;7:e38111.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new microscopy technique, BioSenSRRF, reveals how Aurora kinase A (AURKA) regulates mitochondrial ATP production at the nanoscale in cancer cells....
4 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today